JMJD6 and neoplasm: Results suggested higher tumor expression of JMJD6 in patients with tumor metastasis compared with that of non-metastatic patients (p = 0.017 in LUAD and p = 0.012 in LUSC), indicating that tumor JMJD6 expression is positively associated with metastasis incidence of NSCLC (Fig. 1k).